Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Clinical Trial
A Study of Atezolizumab (Anti−Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling, Phase III
Updated: 12/31/1969
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Clinical Trial
A Study of Atezolizumab (Anti−Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling, Phase III
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Clinical Trial
A Study of Atezolizumab (Anti−Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling, Phase III
Updated: 12/31/1969
The Cleveland Clinic, Taussig Cancer Institute
mi
from
Cleveland, OH
Click here to add this to my saved trials
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Clinical Trial
A Study of Atezolizumab (Anti−Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Georgia Oncology Centers, PC
mi
from
Marietta, GA
Click here to add this to my saved trials
Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) Clinical Trial
A Study of Atezolizumab (Anti−Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Vallejo
mi
from
Vallejo, CA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT
Status: Enrolling, Phase
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT
Status: Enrolling, Phase
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Tourette Syndrome Clinical Trial
Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Teva Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Tourette Syndrome Clinical Trial
Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Teva Investigational Site 12995
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Tourette Syndrome Clinical Trial
Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Teva Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Analgesic Adverse Reaction Clinical Trial
Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy
Status: Enrolling, Phase IV
Updated: 2/27/2018
Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Disuse Atrophy Clinical Trial
The Efficacy of Protein Supplementation on Attenuating Muscle Atrophy Following Disuse in the Collegiate Population
Status: Enrolling
Updated: 3/2/2018
South Dakota State University
mi
from
Brookings, SD
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
SMART Program in Irritable Bowel Syndrome (IBS)
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
CPI-006 Alone and in Combination With CPI-444 and With Pembrolizumab for Patients With Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
CPI-006 Alone and in Combination With CPI-444 and With Pembrolizumab for Patients With Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Yale School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 3/29/2018
St. Joseph Heritage Healthcare
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Non-Small-Cell Lung Clinical Trial
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwell Health/Monter Cancer Center
mi
from
Lake Success, NY
Click here to add this to my saved trials
Non-Small-Cell Lung Clinical Trial
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Status: Enrolling, Phase III
Updated: 12/31/1969
USC Norris Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Non-Small-Cell Lung Clinical Trial
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Non-Small-Cell Lung Clinical Trial
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Clinic - Cancer & Hematology, Site #151
mi
from
Springfield, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Reproductive Clinical Trial
Management of the PDA Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
The Kirklin Clinic of UAB Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
South Medical Research Group, Inc
mi
from
Miami, FL
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
Maine Nephrology Associates
mi
from
Portland, ME
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
Urology of Virginia, PLLC
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Enteric Hyperoxaluria Clinical Trial
Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria
Status: Enrolling, Phase III
Updated: 12/31/1969
Coastal Urology
mi
from
Wilmington, NC
Click here to add this to my saved trials
Clinical Trial
Using an End-of-life Conversation Game to Engage Underserved Communities in Advance Care Planning
Status: Enrolling
Updated: 12/31/1969
Penn State Hershey College of Medicine
mi
from
Hershey, PA
Click here to add this to my saved trials
Epilepsy Clinical Trial
Fycompa Titration Intervals and Effects on Retention Rate
Status: Enrolling, Phase IV
Updated: 12/31/1969
Banner - University Medical Center Phoenix
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Collection of Sputum and Labeling for Lung Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
Waterbury Pulmonary Associates
mi
from
Waterbury, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Liver-Directed Therapy in Treating Patients With Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Liver Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Upper Gastrointestinal Bleeding Clinical Trial
Capsule Endoscopy for HEmorrhage in the ER
Status: Enrolling
Updated: 12/31/1969
Duke University School of Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
Mixed Tumor, Malignant Clinical Trial
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Hospital of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Mixed Tumor, Malignant Clinical Trial
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Mixed Tumor, Malignant Clinical Trial
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Mixed Tumor, Malignant Clinical Trial
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Facioscapulohumeral Muscular Dystrophy Clinical Trial
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Status: Enrolling, Phase
Updated: 12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Facioscapulohumeral Muscular Dystrophy Clinical Trial
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Status: Enrolling, Phase
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Facioscapulohumeral Muscular Dystrophy Clinical Trial
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Status: Enrolling, Phase
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Other Clinical Trial
Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
Dissemination and Implementation of Function Focused Care for Assisted Living
Status: Enrolling
Updated: 12/31/1969
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Musculoskeletal, Neurology Clinical Trial
Dissemination and Implementation of Function Focused Care for Assisted Living
Status: Enrolling
Updated: 12/31/1969
Penn State University
mi
from
State College, PA
Click here to add this to my saved trials
Osteoarthritis Clinical Trial
Precision Assessment of Platelet Rich Plasma for Joint Preservation
Status: Enrolling, Phase
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
ADHD Clinical Trial
KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD
Status: Enrolling, Phase III
Updated: 4/19/2018
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Urological Associates of Southern Arizona, PC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Pediatric Hypertension Clinical Trial
N-of-1 Trials In Children With Hypertension
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Annual Visit, Well Visit Clinical Trial
Increasing Patient Engagement in the Annual Well Visits Program
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Contraception Clinical Trial
Early vs. Interval Postpartum IUD Insertion
Status: Enrolling
Updated: 3/22/2018
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Infection, Human Immunodeficiency Virus Clinical Trial
GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV
Status: Enrolling, Phase
Updated: 3/5/2018
GSK Investigational Site
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Effects of TUDCA on Endothelial Function in Type 2 DM
Status: Enrolling, Phase
Updated: 12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Sarcoma Clinical Trial
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
Status: Enrolling, Phase
Updated: 12/31/1969
James P. Wilmot Cancer Center at University of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Musculoskeletal Clinical Trial
The VIGOR Study - Virtual Immersive Gaming to Optimize Recovery in Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
New Mexico Heart Institute
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
MedStar Health Research Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai Hospital Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
Columbus Regional Research Institute
mi
from
Columbus, GA
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
OHIO State University (OSU) Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE-301
Status: Enrolling, Phase III
Updated: 12/31/1969
Centra Cardiovascular Group
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Institute of Michigan,
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Ohio State University Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
UT Southwestern - Parkland Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Western Connecticut Health Network, Danbury Hospital
mi
from
Danbury, CT
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Research Network
mi
from
Gainesville, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
UC San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Gastroenterology Research
mi
from
Mentor, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Precision Research Institute, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Digestive Disease Consultants
mi
from
Southlake, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
Status: Enrolling, Phase
Updated: 12/31/1969
University of North Carolina at Chapel Hill, Department of Radiation Oncology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Premature Birth of Newborn Clinical Trial
Improving Preterm Infant Outcomes With Family Integrated Care and Mobile Technology
Status: Enrolling
Updated: 12/31/1969
UCSF Benioff Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hurley Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Bronson Methodist Hospital
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Alaska Oncology and Hematology LLC
mi
from
Anchorage, AK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Anchorage Oncology Centre
mi
from
Anchorage, AK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Deer Valley Medical Center
mi
from
Antioch, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory University Hospital-Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
MultiCare Auburn Medical Center
mi
from
Auburn, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Bronson Battle Creek
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Parkland Health Center-Bonne Terre
mi
from
Bonne Terre, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence Saint Joseph Medical Center-Disney Family Cancer Center
mi
from
Burbank, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Ridges Hospital
mi
from
Burnsville, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami Valley Hospital South
mi
from
Centerville, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Centralia Oncology Clinic
mi
from
Centralia, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Bethesda North Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
TriHealth Cancer Institute-Anderson
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Kootenai Medical Center
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Penrose-Saint Francis Healthcare
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Commonwealth Cancer Center-Corbin
mi
from
Corbin, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Carle on Vermilion
mi
from
Danville, IL
Click here to add this to my saved trials